CA Patent

CA2333770A1 — Cell adhesion-inhibiting antinflammatory compounds

Assigned to Abbott Laboratories · Expires 1999-12-09 · 26y expired

What this patent protects

Compounds having Formula (I) are useful for treating inflammation. Also disclosed are pharmaceutical compositions comprising compouns of Formula (I), and methods of inhibiting/treating inflammatory diseases in a mammal.

USPTO Abstract

Compounds having Formula (I) are useful for treating inflammation. Also disclosed are pharmaceutical compositions comprising compouns of Formula (I), and methods of inhibiting/treating inflammatory diseases in a mammal.

Drugs covered by this patent

Patent Metadata

Patent number
CA2333770A1
Jurisdiction
CA
Classification
—
Expires
1999-12-09
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.